Corrigendum to Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs (Bioorganic & Medicinal Chemistry Letters (2010) 20, (3737-3741) DOI: 10.1016/j.bmcl.2010.04.075);Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 12, 2010, Pages 3737-3741

  Wágner, Gábor ^a   Wéber, Csaba ^a   Nyéki, Olga ^a   Nógrádi, Katalin ^a   Bielik, Attila ^a   Molnár, László ^a   Bobok, Amrita ^a   Horváth, Attila ^a   Kiss, Béla ^a   Kolok, Sándor ^a   Nagy, József ^a   Kurkó, Dalma ^a   Gál, Krisztina ^a   Greiner, István ^a   Szombathelyi, Zsolt ^a   Keser, György M ^a   Domány, György ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

mGluR5; Negative allosteric modulator; Parallel synthesis

Indexed keywords

3,5 DISUBSTITUTED OXADIAZOLE; 3,5 DISUBSTITUTED TETRAZOLE; LIGAND; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 5 NEGATIVE ALLOSTERIC MODULATOR; OXADIAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG IDENTIFICATION; DRUG SYNTHESIS; LIPOPHILICITY; STRUCTURE ACTIVITY RELATION;

EID: 77954217162     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.04.112     Document Type: Erratum

References (45)

1. D.D. Schoepp, and P.J. Conn Trends Pharmacol. Sci. 14 1993 13
2. D.D. Schoepp Neurochem. Int. 24 1994 439
3. J.P. Pin, and R. Duvoisin Neuropharmacology 34 1995 1
4. F. Bordi, and A. Ugolini Prog. Neurobiol. 59 1999 55
5. S. Alagarsamy, S.D. Sorensen, and P.J. Conn Curr. Opin. Neurobiol. 11 2001 357
6. W.P. Spooren, F. Gasparini, T.E. Salt, and R. Kuhn Trends Pharmacol. Sci. 22 2001 331
7. W.P. Spooren, A. Vassout, H.C. Neijt, R. Kuhn, F. Gasparini, S. Roux, R.D. Porsolt, and C.J. Gentsch Pharmacol. Exp. Ther. 295 2000 1267
8. K. Walker, A. Reeve, M. Bowes, J. Winter, G. Wotherspoon, A. Davis, P. Schmid, F. Gasparini, R. Kuhn, and L. Urban Neuropharmacology 40 2001 10
9. E. Tatarczyńska, A. Klodzińska, E. Chojnacka-Wójcik, A. Palucha, F. Gasparini, R. Kuhn, and A. Pilc Br. J. Pharmacol. 132 2001 1423
10. A.G. Chapman, K. Nanan, M. Williams, and B.S. Meldrum Neuropharmacology 39 2000 1567
11. V. Bruno, I. Ksiazek, G. Battaglia, S. Lukic, T. Leonhardt, D. Sauer, F. Gasparini, R. Kuhn, F. Nicoletti, and P.J. Flor Neuropharmacology 39 2000 2223
12. V.A. Movsesyan, D.M. O'Leary, L. Fan, W. Bao, P.G. Mullins, S.M. Knoblach, and A.I. Faden J. Pharmacol. Exp. Ther. 296 2001 41
13. K. Ossowska, J. Konieczny, S. Wolfarth, J. Wierońska, and A. Pilc Neuropharmacology 41 2001 413
14. C. Chiamulera, M.P. Epping-Jordan, A. Zocchi, C. Marcon, C. Cottiny, S. Tacconi, M. Corsi, F. Orzi, and F. Conquet Nat. Neurosci. 4 2001 873
15. Allgeier, H.; Auberson, Y.; Biollaz, M.; Cosford, N. D.; Gasparini, F.; Heckendorn, R.; Johnson, E. C.; Kuhn, R.; Varney, M. A.; Velicelebi, G. WO 9902497, 2007.
16. J.A. O'Brien, W. Lemaire, M. Wittmann, M.A. Jacobson, S.N. Ha, D.D. Wisnoski, C.W. Lindsley, H.J. Schaffhauser, B. Rowe, C. Sur, M.E. Duggan, D.J. Pettibone, P.J. Conn, and D.L. Williams Jr. J. Pharmacol. Exp. Ther. 309 2004 568
17. J.C. Pecknold, D.J. McClure, L. Appeltauer, L. Wrzesinski, and T.J. Allan Clin. Psychopharmacol. 2 1982 129
18. R.H. Porter, G. Jaeschke, W. Spooren, T.M. Ballard, B. Büttelmann, S. Kolczewski, J.U. Peters, E. Prinssen, J. Wichmann, E. Vieira, A. Mühlemann, S. Gatti, V. Mutel, and P.J. Malherbe Pharmacol. Exp. Ther. 315 2005 711
19. G. Jaeschke, J.G. Wettstein, R.E. Nordquist, and W. Spooren Expert Opin. Ther. Patents 18 2008 123
20. Galambos, J.; Vastag, M.; Bobok, A. Á.; Keser, G. M.; Gál, K.; Benk, B.; Rill, A.; Demeter, Á. WO 2007072089, 2007.
21. Nógrádi, K.; Wágner, G. A.; Keser, G. M.; Bielik, A.; Gáti, T.; Háda, V.; Kóti, J.; Gál, K.; Vastag, M.; Bobok, A. Á. WO 2007072090, 2007.
22. Nógrádi, K.; Keser, G. M.; Bielik, A.; Gáti, T.; Gál, K.; Vastag, M.; Bobok, A. Á. WO 2007072091, 2007.
23. Keser, G. M.; Wéber, C.; Bielik, A.; Bobok, A. Á.; Gál, K.; Meszlényiné S. M.; Molnár, L.; Vastag, M. WO 2007072093, 2007.
24. Nógrádi, K.; Wágner, G. A.; Keser, G. M.; Bielik, A.; Gáti, T.; Háda, V.; Kóti, J.; Gál, K.; Vastag, M.; Bobok, A. Á. WO 2007072094, 2007.
25. Nógrádi, K.; Wágner, G. A.; Keser, G. M.; Bielik, A.; Gáti, T.; Háda, V.; Kóti, J.; Gál, K.; Vastag, M.; Bobok, A. Á. WO 2007072095, 2007.
26. d was determined from the Scatchard plot.
27. 50 determination sigmoidal (4-parameter) concentration-inhibition curves were fitted to the percent inhibition data derived from at least three independent experiments using GraphPad Prism software.
28. J.W.M.J. Nissink Chem. Inf. Model. 49 2009 1617
29. G.M. Keser, and G.M. Makara Nat. Rev. Drug Disc. 8 2009 203
30. Gál, K.; Wéber, C.; Wágner, G. A.; Horváth, A.; Nyéki, G.; Vastag, M.; Keser, G. M. WO 2007039781, 2007.
31. R.F. Poulain, A.L. Tartar, and D.P. Déprez Tetrahedron Lett. 42 2001 1495
32. A.R. Gangloff, J. Litvak, E.J. Shelton, D. Sperandio, V.R. Wang, and K.D. Rice Tetrahedron Lett. 42 2001 1441
33. Gál, K.; Wéber, C.; Wágner, G. A.; Bobok, A. Á.; Nyéki, G.; Vastag, M.; Keser, G. M.; Háda, V.; Kóti, J. WO 2007039782, 2007.
34. G. Balboni, M. Marastoni, M. Merighi, P.A. Borea, and R. Tomatis Eur. J. Med. Chem. 35 2000 979
35. S. Chandrasekhar, M.V. Reddy, and G. Rajaiahet Tetrahedron Lett. 41 2000 10131
36. S. Ito, Y. Tanaka, A. Kakehi, and K. Kondo Bull. Chem. Soc. Jpn. 49 1976 1920
37. A.S. Shawali, A.A. Fahmi, and N.F.J. Eweiss Heterocyclic Chem. 16 1979 123
38. Merck&Co. Inc.: Cosford, N. D.; Roppe, J.; Chen, C.; Smith, N.; Reger, T. WO 2003029210, 2003.
39. Smith, N. D.; Cosford, N. D. P.; Reger, T. R.; Roppe, J. R.; Poon, S. F.; Huang, D.; Chen, C.; Eastman, B. W. WO 2003077918; AstraZeneca AB
40. Wensbo, D.; Xin, T.; Stefanac, T.; Arora, J.; Edwards, L.; Isaac, M.; Slassi, A.; Stefanac, T. WO 2004014902, 2004.
41. Wensbo, D.; Edwards, L.; Isaac, M.; McLeod, D. A.; Slassi, A.; Xin, T.; Stormann, T. M. WO 2005066155, 2005.
42. Johansson, M.; Minidis, A.; Staaf, K.; Wensbo, D.; McLeod, D. A.; Edwards, L.; Isaac, M.; O'Brien, A.; Slassi, A.; Xin, T. WO 2005080356, 2005.
43. Arora, J.; Edwards, L.; Isaac, M.; Kers, A.; Staaf, K.; Slassi, A.; Stefanac, T.; Wensbo, D.; Xin, T.; Holm, B. WO 2005080386. 2005.
44. Isaac, M.; Slassi, A.; Edwards, L.; Xin, T.; Stefanac, T. WO 2007130821, 2007.
45. Isaac, M.; Slassi, A.; Edwards, L.; Xin, T.; Stefanac, T. WO 2007130822, 2007; Addex Pharm. SA: (i) Bessis, A.; Bonnet, B.; Le Poul, E.; Rocher, J.; Epping-Jordan, M. WO 2005044797, 2007.